Injection

Prevention of Hepatitis A Virus Infection in the US: Recommendations of the ACIP

Jul 02, 2020 | Kimberly Sharpe-Scott

The CDC, in collaboration with the Advisory Committee on Immunization Practices (ACIP), published new recommendations for hepatitis A vaccination. The recently released MMWR, Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020, highlights the following key messages:

  • Hepatitis A vaccines were first recommended by ACIP in 1996 and the last full recommendations and report was published 14 years ago in 2006, when ACIP recommended routine hepatitis A vaccination of all children aged 12–23 months.
  • The hepatitis A virus (HAV) is transmitted via the fecal-oral route, usually through direct person-to-person contact or consumption of contaminated food or water.
  • Illness is usually mild and self-limited when healthy persons are infected, however disease severity increases in persons who are older or immunocompromised, have chronic liver disease, or have other underlying health conditions.
  • After the introduction of hepatitis A vaccination in 1996, reported hepatitis A cases fell over 95% between 1996 and 2011.
  • Since then small increases in cases occurred in 2013 and 2016 attributed to foodborne outbreaks associated with contaminated food; then, beginning in 2016, greater increases in the number of reported cases occurred across the United States, primarily from widespread outbreaks of hepatitis A from person-to-person transmission resulting in a sharp increase in cases from 2,007 in 2016 to 12,474 in 2018.
  • Low adult HepA vaccination coverage and high population susceptibility to HAV infection allow outbreaks to continue to occur.
  • These outbreaks have led the Advisory Committee on Immunization Practices to review the data on vaccination and prepare new hepatitis A recommendations to decrease HAV incidence and prevent future outbreaks.

The new and updated ACIP recommendations include, but are not limited to:

  • Vaccination of all children and adolescents aged 2–18 years who have not previously received HepA vaccine (catch-up vaccination)
  • Vaccination of all persons aged ≥1 year infected with human immunodeficiency virus (HIV)
  • Vaccination of pregnant women who are identified to be at risk for HAV infection during pregnancy or for having a severe outcome from HAV infection
  • Vaccination during hepatitis A outbreaks of persons aged ≥1 year who are at risk for HAV infection or who are at risk for severe disease from HAV
  • Vaccination in settings providing services to adults in which a high proportion of persons have risk factors for HAV infection (e.g., health care settings with a focus on those who use injection or non-injection drugs, group homes, and nonresidential day care facilities for developmentally disabled persons)

Access the recently released MMWR detailing updated hepatitis A vaccination recommendations here.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

Related Posts

  • Health & Disability
  • Opportunity

NACCHO Announces Recruitment for the 2020-2021 Health...

The National Association of County and City Health Officials (NACCHO) is...

Aug 11, 2020

NACCHO Announces Recruitment for the 2020-2021 Health...

  • Antibiotic Resistance

New Study Reveals Barriers to Combating Antibiotic...

New survey research from Pew and the American Medical Association reveals...

Aug 06, 2020 | Kim Rodgers

New Study Reveals Barriers to Combating Antibiotic...

Covid Contact Tracing Banner
  • Contact Tracing

NACCHO Launches Online Hub for Contact Tracing Resources

To support LHDs as they design, establish, scale up, and strengthen their...

Aug 06, 2020

NACCHO Launches Online Hub for Contact Tracing Resources

  • Tools & Resources
  • HIV, STI, & Viral Hepatitis
  • Opioid Overdose Epidemic

Guide to Integrating HCV Services into Opioid Treatment...

The Addiction Technology Transfer Care Network released a new tool, Your Guide...

Aug 05, 2020 | Kat Kelley

Guide to Integrating HCV Services into Opioid Treatment...

Campaign lets stop hiv together
  • Tools & Resources
  • HIV, STI, & Viral Hepatitis

Let’s Stop HIV Together Videos: “Doing It” Campaign

The Let’s Stop HIV Together campaign from CDC has a series of videos designed...

Aug 05, 2020 | Julia Zigman (she/her)

Let’s Stop HIV Together Videos: “Doing It” Campaign

AIDS Vu Logo
  • Tools & Resources
  • HIV, STI, & Viral Hepatitis

AIDSVu 2018 Prevalence and Incidence Maps

AIDSVu has updated its interactive maps and data to 2018 prevalence and 2018...

Aug 05, 2020 | Julia Zigman (she/her)

AIDSVu 2018 Prevalence and Incidence Maps

Endhivepidemic designa
  • HIV, STI, & Viral Hepatitis

CDC Awards $109 Million to Local Areas and States for...

The Centers for Disease Control and Prevention awarded $109 million to 32 state...

Aug 05, 2020 | Julia Zigman (she/her)

CDC Awards $109 Million to Local Areas and States for...

HRSA Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

HRSA Launches PLOS Special Collection Highlighting Ryan...

HRSA launches a new collection of manuscripts in PLOS (Public Library of...

Aug 05, 2020 | Julia Zigman (she/her)

HRSA Launches PLOS Special Collection Highlighting Ryan...

Special needs
  • COVID-19
  • Infectious Disease
  • Maternal, Child, & Adolescent Health

NACCHO Recruiting Members for Collaborative Workgroup on...

, NACCHO is looking to expand the Maternal-Child, Infectious Disease, and...

Aug 05, 2020 | Adelaide Appiah

NACCHO Recruiting Members for Collaborative Workgroup on...

Back to Top